Adam, A. M., Atkinson, P. F., Hall, S. M., Hughes, R. A. and Taylor, W. A. (1989). Chronic experimental allergic neuritis in Lewis rats. Neuropathol Appl Neurobiol 15, 249–64.CrossRefGoogle ScholarPubMed

Adams, D., Festenstein, H., Gibson, J. D.et al. (1979). HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy. J Neurol Neurosurg Psychiatry 42, 184–6.CrossRefGoogle ScholarPubMed

Agresti, C., D'Urso, D. and Levi, G. (1996). Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8, 1106–16.CrossRefGoogle ScholarPubMed

Ahmed, M. R., Basha, S. H., Gopinath, D., Muthusamy, R. and Jayakumar, R. (2005). Initial upregulation of growth factors and inflammatory mediators during nerve regeneration in the presence of cell adhesive peptide-incorporated collagen tubes. J Peripher Nerv Syst 10, 17–30.CrossRefGoogle ScholarPubMed

Ahn, M., Lee, Y., Moon, C.et al. (2004). Upregulation of osteopontin in Schwann cells of the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Neurosci Lett 372, 137–41.CrossRefGoogle ScholarPubMed

Ainsworth, P. J., Bolton, C. F., Murphy, B. C., Stuart, J. A. and Hahn, A. F. (1998). Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet 103, 242–4.CrossRefGoogle ScholarPubMed

Akassoglou, K., Probert, L., Kontogeorgos, G. and Kollias, G. (1997). Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158, 438–45.Google Scholar

Akassoglou, K., Bauer, J., Kassiotis, G.et al. (1998). Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153, 801–13.CrossRefGoogle ScholarPubMed

Akassoglou, K., Bauer, J., Kassiotis, G.et al. (1999). Transgenic models of TNF induced demyelination. Adv Exp Med Biol 468, 245–59.CrossRefGoogle ScholarPubMed

Akassoglou, K., Kombrinck, K. W., Degen, J. L. and Strickland, S. (2000). Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149, 1157–66.CrossRefGoogle ScholarPubMed

Akassoglou, K., Yu, W. M., Akpinar, P. and Strickland, S. (2002). Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 33, 861–75.CrossRefGoogle ScholarPubMed

Al-Din, A. N., Anderson, M., Bickerstaff, E. R. and Harvey, I. (1982). Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain 105 (Pt 3), 481–95.CrossRefGoogle Scholar

Albrecht, D. E. and Froehner, S. C. (2004). DRP2 and Dp116 Form Spatially Distinct Dystrophin-like Complexes in the Schwann Cells of Peripheral Nerves. American Society for Cell Biology, Washington DC, Abstract.Google Scholar

Allen, D., Giannopoulos, K., Gray, I.et al. (2005). Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 10, 174–80.CrossRefGoogle ScholarPubMed

Allen, N. J., Barres, B. A. (2005). Signaling between glia and neurons: focus on synaptic plasticity. Curr Opin Neurobiol 15, 542–8.CrossRefGoogle ScholarPubMed

Altevogt, B. M., Kleopa, K. A., Postma, F. R., Scherer, S. S. and Paul, D. L. (2002). Cx29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22, 6458–70.CrossRefGoogle ScholarPubMed

Alvarez-Buylla, A. and Lim, D. A. (2004). For the long run: maintaining germinal niches in the adult brain. Neuron 41, 683–6.CrossRefGoogle Scholar

American Academy of Neurology (1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41, 617–18.CrossRef

Ammoumi, A. A., Pertschuk, L., Daras, M. and Rosen, A. D. (1980). Guillain–Barré syndrome; results of direct immunofluorescent study. NY State J Med 80, 1434–5.Google ScholarPubMed

Andorfer, B., Kieseier, B. C., Mathey, E.et al. (2001). Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116, 226–32.CrossRefGoogle ScholarPubMed

Andrews, T., Zhang, P. and Bhat, N. R. (1998). TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54, 574–83.3.0.CO;2-0>CrossRefGoogle ScholarPubMed

Anzini, P., Neuberg, D. H., Schachner, M.et al. (1997). Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 17, 4545–51.CrossRefGoogle ScholarPubMed

Aoki, E., Semba, R. and Kashiwamata, S. (1991). Evidence for the presence of L-arginine in the glial components of the peripheral nervous system. Brain Res 559, 159–62.CrossRefGoogle ScholarPubMed

Apostolski, S., Sadiq, S. A., Hays, A.et al. (1994). Identification of Gal(beta 1–3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 38, 134–41.CrossRefGoogle ScholarPubMed

Araque, A., Parpura, V., Sanzgiri, R. P. and Haydon, P. G. (1999). Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22, 208–15.CrossRefGoogle ScholarPubMed

Archelos, J. J., Roggenbuck, K., Schneider-Schaulies, J., Linington, C., Toyka, K. V. and Hartung, H. P. (1993). Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res 35, 46–53.CrossRefGoogle ScholarPubMed

Arenander, A. and De Vellis, J. (1999). Development of the nervous system. Siegel, G. (Ed.) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Raven Press, New York, pp. 573–606.Google Scholar

Argall, K. G., Armati, P. J., Pollard, J. D. and Bonner, J. (1992a). Interactions between CD4+ T-cells and rat Schwann cells in vitro. 2. Cytotoxic effects of P2-specific CD4+ T-cell lines on Lewis rat Schwann cells. J Neuroimmunol 40, 19–29.CrossRefGoogle Scholar

Argall, K. G., Armati, P. J., Pollard, J. D., Watson, E. and Bonner, J. (1992b). Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines. J Neuroimmunol 40, 1–18.CrossRefGoogle Scholar

Armati, P. J. and Pollard, J. D. (1987). Cytotoxic response of serum from patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Acta Neurol Scand 76, 24–7.CrossRefGoogle Scholar

Armati, P. J. and Pollard, J. D. (1996). Immunology of the Schwann cell. Baillieres Clin Neurol 5, 47–64.Google ScholarPubMed

Armati, P. J., Pollard, J. D. and Gatenby, P. (1990). Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13, 106–16.CrossRefGoogle ScholarPubMed

Arroyo, E. J. and Scherer, S. S. (2000). On the molecular architecture of myelinated fibers. Histochem Cell Biol 113, 1–18.CrossRefGoogle ScholarPubMed

Arroyo, E. J., Sirkowski, E. E., Chitale, R. and Scherer, S. S. (2004). Acute demyelination disrupts the molecular organization of PNS nodes. J Comp Neurol 479, 424–34.CrossRefGoogle Scholar

Arteaga, M. F., Gutierrez, R., Avila, J., Mobasheri, A., Diaz-Flores, L. and Martin-Vasallo, P. (2004). Regeneration influences expression of the Na+, K+-atpase subunit isoforms in the rat peripheral nervous system. Neuroscience 129, 691–702.CrossRefGoogle ScholarPubMed

Asbury, A. K. and Cornblath, D. R. (1990). Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27 Suppl, S21–4.CrossRefGoogle ScholarPubMed

Asbury, A. K., Arnason, B. G. and Adams, R. D. (1969). The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48, 173–215.CrossRefGoogle ScholarPubMed

Asbury, A. K., Arnason, B. G. W., Karp, H. R. and McFarlin, D. F. (1978). Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol 3, 565–6.Google Scholar

Astrow, S. H., Son, Y. J. and Thompson, W. J. (1994). Differential neural regulation of a neuromuscular junction-associated antigen in muscle fibers and Schwann cells. J Neurobiol 25, 937–52.CrossRefGoogle ScholarPubMed

Astrow, S. H., Tyner, T. R., Nguyen, M. T. and Ko, C. P. (1997). A Schwann cell matrix component of neuromuscular junctions and peripheral nerves. J Neurocytol 26, 63–75.CrossRefGoogle ScholarPubMed

Astrow, S. H., Qiang, H. and Ko, C. P. (1998). Perisynaptic Schwann cells at neuromuscular junctions revealed by a novel monoclonal antibody. J Neurocytol 27, 667–81.CrossRefGoogle ScholarPubMed

Asundi, V. K., Erdman, R., Stahl, R. C. and Carey, D. J. (2003). Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells. J Neurosci Res 73, 593–602.CrossRefGoogle ScholarPubMed

Atanasoski, S., Notterpek, L., Lee, H. Y.et al. (2004). The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43, 499–511.CrossRefGoogle ScholarPubMed

Augustien, G. J., Burns, M. E., DeBello, W. M.et al. (1999). Proteins involved in synaptic vesicle trafficking. J Physiol 520, 33–41.CrossRefGoogle Scholar

Auld, D. S. and Robitaille, R. (2003a). Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron 40, 389–400.CrossRefGoogle Scholar

Auld, D. S. and Robitaille, R. (2003b). Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 9, 144–57.CrossRefGoogle Scholar

Auld, D. S., Colomar, A., Belair, E. L.et al. (2003). Modulation of neurotransmission by reciprocal synapse–glial interactions at the neuromuscular junction. J Neurocytol 32, 1003–15.CrossRefGoogle ScholarPubMed

Awasaki, T. and Ito, K. (2004). Engulfing action of glial cells is required for programmed axon pruning during Drosophila metamorphosis. Curr Biol 14, 668–77.CrossRefGoogle ScholarPubMed

Awatramani, R., Shumas, S., Kamholz, J. and Scherer, S. S. (2002). TGFbeta1 modulates the phenotype of Schwann cells at the transcriptional level. Mol Cell Neurosci 19, 307–19.CrossRefGoogle ScholarPubMed

Bachelin, C., Lachapelle, F., Girard, C.et al. (2005). Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. Brain 128, 540–9.CrossRefGoogle ScholarPubMed

Baggiolini, M. (2001). Chemokines in pathology and medicine. J Intern Med 250, 91–104.CrossRefGoogle Scholar

Bai, Y., Ianokova, E., Pu, Q.et al. (in press). R69C mutation in myelin protein zero causes early onset CMT1B with demyelination, dysmyelination and axonal loss. Arch Neurol.Google Scholar

Balarezo, F. S., Muller, R. C., Weiss, R. G.et al. (2003). Soft tissue perineuriomas in children: report of three cases and review of the literature corrected. Pediatr Dev Pathol 6, 137–41.CrossRefGoogle ScholarPubMed

Balice-Gordon, R. J., Bone, L. J. and Scherer, S. S. (1998). Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 142, 1095–104.CrossRefGoogle ScholarPubMed

Ballesteros, J. A., Abrams, C. K., Oh, S., Verselis, V. K., Weinstein, H. and Bargiello, T. A. (1999). The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophy J 76, 2887–98.Google Scholar

Bao, J., Wolpowitz, D., Role, L. W. and Talmage, D. A. (2003). Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161, 1133–41.CrossRefGoogle ScholarPubMed

Barohn, R. J., Kissel, J. T., Warmolts, J. R. and Mendell, J. R. (1989). Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46, 878–84.CrossRefGoogle ScholarPubMed

Baron Van Evercooren, A., Kleiman, H. K., Seppa, J., Rentier, B. and Dubois-Dalcq, M. (1982). Fibronectin promotes rat Schwann cell growth and motility. J Cell Biol 93, 211–16.CrossRefGoogle ScholarPubMed

Baxter, R. V., Ben Othmane, K., Rochelle, J. M.et al. (2001). Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot–Marie–Tooth disease type 4A/8q21. Nat Genet 30, 21–2.CrossRefGoogle ScholarPubMed

Be'eri, H., Reichert, F., Saada, A. and Rotshenker, S. (1998). The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci 10, 2707–13.CrossRefGoogle ScholarPubMed

Beams, H. W. and Evans, T. C. (1953). Electron micrographs of motor end-plates. Proc Soc Exp Biol Med 82, 344–6.CrossRefGoogle ScholarPubMed

Bellone, E., Di Maria, E., Soriani, S.et al. (1999). A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease. Hum Mutat 14, 353–4.3.0.CO;2-4>CrossRefGoogle ScholarPubMed

Belmadani, A., Tran, P. B., Ren, D., Assimacopoulos, S., Grove, E. A. and Miller, R. J. (2005). The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J Neurosci 25, 3995–4003.CrossRefGoogle ScholarPubMed

Bennett, V. and Baines, A. J. (2001). Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev 81, 1353–92.CrossRefGoogle ScholarPubMed

Bennett, C. L., Shirk, A. J., Huynh, H. M.et al. (2004). SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann Neurol 55, 713–20.CrossRefGoogle ScholarPubMed

Berciano, J., Garcia, A., Calleja, J. and Combarros, O. (2000). Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication. Neuromuscul Disord 10, 419–24.CrossRefGoogle ScholarPubMed

Bergoffen, J., Scherer, S. S., Wang, S.et al. (1993). Connexin mutations in X-linked Charcot–Marie–Tooth disease. Science 262, 2039–42.CrossRefGoogle ScholarPubMed

Bergsteinsdottir, K., Kingston, A., Mirsky, R. and Jessen, K. R. (1991). Rat Schwann cells produce interleukin-1. J Neuroimmunol 34, 15–23.CrossRefGoogle ScholarPubMed

Bergsteinsdottir, K., Kingston, A. and Jessen, K. R. (1992). Rat Schwann cells can be induced to express major histocompatibility complex class II molecules in vivo. J Neurocytol 21, 382–90.CrossRefGoogle ScholarPubMed

Bermingham, J. R., Scherer, S. S., O'Connell, S.et al. (1996). Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes & Development 10, 1751–62.CrossRefGoogle ScholarPubMed

Bermingham, J. R. Jr., Shearin, H., Pennington, J.et al. (2006). The claw paw mutation reveals a role for Lgi4 in peripheral nerve development. Nat Neurosci 9, 76–84.CrossRefGoogle ScholarPubMed

Berthold, C. H., Fraher, J. P., King, R. H. M. and Rydmark, M. (2005). Microscopic anatomy of the peripheral nervous system. Dyck, P. J., Thomas, P. K. (Eds.) Peripheral Neuropathy, 4th Edn, Elsevier Saunders, Philadelphia, PA, pp. 35–92.Google Scholar

Bigbee, J. W., Yoshino, J. E. and DeVries, G. H. (1987). Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol 16, 487–96.CrossRefGoogle ScholarPubMed

Bigotte, L., Arvidson, B. and Olsson, Y. (1982). Cytofluorescence localization of adriamycin in the nervous system. II. Distribution of the drug in the somatic and autonomic peripheral nervous systems of normal adult mice after intravenous injection. Acta Neuropathol (Berl) 57, 130–6.CrossRefGoogle ScholarPubMed

Birks, R., Huxley, H. E. and Katz, B. (1960a). The fine structure of the neuromuscular junction of the frog. J Physiol 150, 134–44.CrossRefGoogle Scholar

Birks, R., Katz, B. and Miledi, R. (1960b). Physiological and structural changes at the amphibian myoneural junction, in the course of nerve degeneration. J Physiol 150, 145–68.CrossRefGoogle Scholar

Bishop, D. L., Misgeld, T., Walsh, M. K., Gan, W. B. and Lichtman, J. W. (2004). Axon branch removal at developing synapses by axosome shedding. Neuron 44, 651–61.CrossRefGoogle ScholarPubMed

Bitgood, M. J. and McMahon, A. P. (1995). Hedgehog and Bmp genes are coexpressed at many diverse sites of cell–cell interaction in the mouse embryo. Develop Biol 172, 126–38.CrossRefGoogle ScholarPubMed

Bixby, S., Kruger, G. M., Mosher, J. T., Joseph, N. M. and Morrison, S. J. (2002). Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 35, 643–56.CrossRefGoogle ScholarPubMed

Bjartmar, C., Wujek, J. R. and Trapp, B. D. (2003). Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206, 165–71.CrossRefGoogle ScholarPubMed

Blakemore, W. F. (2005). The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol Appl Neurobiol 31, 1–10.CrossRefGoogle ScholarPubMed

Blanchard, A. D., Sinanan, A., Parmantier, E.et al. (1996). Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res 46, 630–40.3.0.CO;2-0>CrossRefGoogle ScholarPubMed

Boeke, J. (1949). The sympathetic endformation, its synaptology, the interstitial cells, the periterminal network, and its bearing on the neurone theory. Acta Anatomica 8, 18–61.CrossRefGoogle ScholarPubMed

Boerkoel, C. F., Takashima, H., Stankiewicz, P.et al. (2001). Periaxin mutations cause recessive Dejerine–Sottas neuropathy. Am J Hum Genet 68, 325–33.CrossRefGoogle ScholarPubMed

Boiko, T., Rasband, M. N., Levinson, S. R.et al. (2001). Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30, 91–104.CrossRefGoogle ScholarPubMed

Bolin, L. M., Verity, A. N., Silver, J. E., Shooter, E. M. and Abrams, J. S. (1995). Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 64, 850–8.CrossRefGoogle ScholarPubMed

Bolino, A., Muglia, M., Conforti, F. L. (2000). Charcot–Marie–Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25, 17–19.CrossRefGoogle ScholarPubMed

Bonetti, B., Valdo, P., Stegagno, C.et al. (2000). Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J Neuropathol Exp Neurol 59, 74–84.CrossRefGoogle ScholarPubMed

Bonnon, C., Goutebroze, L., Denisenko Nehrbass, N., Girault, J. A. and Faivre Sarrailh, C. (2003). The paranodal complex of F3/Contactin and Caspr/Paranodin traffics to the cell surface via a non-conventional pathway. J Biol Chem 278, 48339–47.CrossRefGoogle Scholar

Bouchard, C., Lacroix, C., Plante, V.et al. (1999). Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52, 498–503.CrossRefGoogle ScholarPubMed

Bourde, O., Kiefer, R., Toyka, K. V. and Hartung, H. P. (1996). Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 69, 135–40.Google ScholarPubMed

Bourque, M. J. and Robitaille, R. (1998). Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction. J Physiol 512 (Pt 1), 197–209.CrossRefGoogle ScholarPubMed

Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W. and Taylor, J. M. (1985). Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76, 1501–13.CrossRefGoogle ScholarPubMed

Bradley, W. G. and Jenkison, M. (1973). Abnormalities of peripheral nerves in murine muscular dystrophy. J Neurol Sci 18, 227–47.CrossRefGoogle ScholarPubMed

Bradley, W. G., Jaros, E. and Jenkison, M. (1977). The nodes of Ranvier in the nerves of mice with muscular dystrophy. J Neuropathol Exp Neurol 36, 797–806.CrossRefGoogle ScholarPubMed

Brady, S. T., Witt, A. S., Kirkpatrick, L. L.et al. (1999). Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurosci 19, 7278–88.CrossRefGoogle ScholarPubMed

Braun, N., Sevigny, J., Robson, S. C., Hammer, K., Hanani, M. and Zimmermann, H. (2004). Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system. Glia 45, 124–32.CrossRefGoogle ScholarPubMed

Braunewell, K. H., Martini, R., LeBaron, R.et al. (1995). Up-regulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican. Eur J Neurosci 7, 792–804.CrossRefGoogle ScholarPubMed

Bray, G. M., Perkins, S., Peterson, A. C. and Aguayo, A. J. (1977). Schwann cell multiplication deficit in nerve roots of newborn dystrophic mice. A radioautographic and ultrastructural study. J Neurol Sci 32, 203–12.CrossRefGoogle ScholarPubMed

Brechenmacher, C., Vital, C., Deminiere, C.et al. (1987). Guillain–Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 6, 19–24.Google ScholarPubMed

Brennan, A., Dean, C. H., Zhang, A. L., Cass, D. T., Mirsky, R. and Jessen, K. R. (2000). Endothelins control the timing of Schwann cell generation in vitro and in vivo. Develop Biol 227, 545–57.CrossRefGoogle ScholarPubMed

Brett, F. M., Costigan, D., Farrell, M. A.et al. (1998). Merosin-deficient congenital muscular dystrophy and cortical dysplasia. Eur J Paediatr Neurol 2, 77–82.CrossRefGoogle ScholarPubMed

Britsch, S., Li, L., Kirchhoff, S.et al. (1998). The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes & Development 12, 1825–36.CrossRefGoogle ScholarPubMed

Britsch, S., Goerich, D. E., Riethmacher, D.et al. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes & Development 15, 66–78.CrossRefGoogle ScholarPubMed

Brown, M. C., Holland, R. L. and Hopkins, W. G. (1981). Motor nerve sprouting. Ann Rev Neurosci 4, 17–42.CrossRefGoogle ScholarPubMed

Bruck, W. (1997). The role of macrophages in Wallerian degeneration. Brain Pathol 7, 741–52.CrossRefGoogle ScholarPubMed

Bruzzone, R. and Ressot, C. (1997). Connexins, gap junctions and cell–cell signalling in the nervous system. Eur J Neurosci 9, 1–6.CrossRefGoogle Scholar

Bruzzone, R., White, T. W., Scherer, S. S., Fischbeck, K. H. and Paul, D. L. (1994). Null mutations of connexin32 in patients with X-linked Charcot–Marie–Tooth disease. Neuron 13, 1253–60.CrossRefGoogle ScholarPubMed

Bruzzone, R., White, T. W. and Paul, D. L. (1996). Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238, 1–27.CrossRefGoogle ScholarPubMed

Bult, C., Kibbe, W. A., Snoddy, J.et al. (2004). A genome end-game: understanding gene function in the nervous system. Nat Neurosci 7, 484–5.CrossRefGoogle Scholar

Bunge, M. B. (1993a). Schwann cell regulation of extracellular matrix biosynthesis and assembly. Dyck, P. J., Thomas, P. K., Griffin, J., Low, P. A., Poduslo, J. F. (Eds.) Peripheral Neuropathy, 3rd Edn, W. B. Saunders, Philadelphia, pp. 299–316.Google Scholar

Bunge, R. P. (1993b). Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Current Opin Neurobiol 3, 805–9.CrossRefGoogle Scholar

Bunge, R. P. (1994). The role of the Schwann cell in trophic support and regeneration. J Neurol 242, S19–S21.CrossRefGoogle ScholarPubMed

Bunge, M. W. P. and Wood, P. (2006). Transplantation of Schwann cells and olfactory ensheathing cells to promote regeneration in the CNS. Selzer, M.et al. (Eds.) Textbook of Neural Repair and Rehabilitation. Cambridge University Press, Cambridge. pp. 513–31.Google Scholar

Bunge, R. P. and Bunge, M. B. (1983). Interrelationship between Schwann cell function and extracellular matrix production. Trends Neurosci499–505.CrossRefGoogle Scholar

Byers, T. J., Lidov, H. G. and Kunkel, L. M. (1993). An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4, 77–81.CrossRefGoogle ScholarPubMed

Caccamo, D. V., Ho, K. L. and Garcia, J. H. (1992). Cauda equina tumor with ependymal and paraganglionic differentiation. Hum Pathol 23, 835–38.CrossRefGoogle ScholarPubMed

Cajal, S. R., DeFelipe, J. and Jones, E. G. (1991). Cajal's Degeneration and Regeneration of the Nervous System. Oxford University Press, Oxford.CrossRefGoogle Scholar

Calabresi, P. A., Fields, N. S., Maloni, H. W.et al. (1998). Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS. Neurology 51, 289–92.CrossRefGoogle ScholarPubMed

Cambier, J. C., Littman, D. R. and Weiss, A. (2001). Antigen presentation to T lymphocytes. Janeway, J. (Ed.) Immunobiology. Garland Publishing, New York.Google Scholar

Cameron-Curry, P. (1995). Glial lineage of the peripheral nervous system. C R Seances Soc Biol Fil 189, 253–61.Google ScholarPubMed

Cameron-Curry, P., Dulac, C. and Douarin, N. M. (1993). Negative regulation of Schwann cell myelin protein gene expression by the dorsal root ganglionic microenvironment. Eur J Neurosci 5, 594–604.CrossRefGoogle ScholarPubMed

Cammer, W. and Tansey, F. A. (1987). Immunocytochemical localization of carbonic anhydrase in myelinated fibers in peripheral nerves of rat and mouse. J Histochem Cytochem 35, 865–70.CrossRefGoogle Scholar

Campana, W. M. and Myers, R. R. (2003). Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci 18, 1497–506.CrossRefGoogle ScholarPubMed

Campana, W. M., Myers, R. R. and Rearden, A. (2003). Identification of PINCH in Schwann cells and DRG neurons: shuttling and signaling after nerve injury. Glia 41, 213–23.CrossRefGoogle ScholarPubMed

Cao, G. and Ko, C. P. (2001). Schwann cell-conditioned medium modulates synaptic activities at Xenopus neuromuscular junctions in vitro. Society for Neuroscience Abstracts, 711, 12.Google Scholar

Carey, D. J. (1997). Syndecans: multifunctional cell-surface co-receptors. Biochem J 327 (Part 1), 1–16.CrossRefGoogle ScholarPubMed

Carey, D. J., Todd, M. S. and Rafferty, C. M. (1986). Schwann cell myelination: induction by exogenous basement membrane-like extracellular matrix. J Cell Biol 102, 2254–63.CrossRefGoogle ScholarPubMed

Carey, D. J., Crumbling, D. M., Stahl, R. C. and Evans, D. M. (1990). Association of cell surface heparan sulfate proteoglycans of Schwann cells with extracellular matrix proteins. J Biol Chem 265, 20627–33.Google ScholarPubMed

Carey, D. J., Evans, D. M., Stahl, R. C.et al. (1992). Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J Cell Biol 117, 191–201.CrossRefGoogle ScholarPubMed

Carey, D. J., Stahl, R. C., Asundi, V. K. and Tucker, B. (1993). Processing and subcellular distribution of the Schwann cell lipid-anchored heparan sulfate proteoglycan and identification as glypican. Exp Cell Res 208, 10–18.CrossRefGoogle ScholarPubMed

Carey, D. J., Stahl, R. C., Cizmeci-Smith, G. and Asundi, V. K. (1994). Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J Cell Biol 124, 161–70.CrossRefGoogle ScholarPubMed

Castonguay, A. and Robitaille, R. (2001). Differential regulation of transmitter release by presynaptic and glial Ca2+ internal stores at the neuromuscular synapse. J Neurosci 21, 1911–22.CrossRefGoogle ScholarPubMed

Castro, C., Gomez-Hernandez, J. M., Silander, K. and Barrio, L. C. (1999). Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 19, 3752–60.CrossRefGoogle ScholarPubMed

Causey, G. (1960). The Cell of Schwann. E&S Livingstone Ltd, Edinburgh.Google Scholar

Cavaletti, G., Fabbrica, D., Minoia, C., Frattola, L. and Tredici, G. (1998). Carboplatin toxic effects on the peripheral nervous system of the rat. Ann Oncol 9, 443–7.CrossRefGoogle ScholarPubMed

Ceuterick-de Groote, C., Jonghe, P., Timmerman, V. (2001). Infantile demyelinating neuropathy associated with a de novo point mutation on Ser72 in PMP22 and basal lamina onion bulbs in skin biopsy. Pathol Res Pract 197, 193–8.CrossRefGoogle ScholarPubMed

Chalasani, S. H., Baribaud, F., Coughlan, C. M.et al. (2003a). The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J Neurosci 23, 4601–12.CrossRefGoogle Scholar

Chalasani, S. H., Sabelko, K. A., Sunshine, M. J., Littman, D. R. and Raper, J. A. (2003b). A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J Neurosci 23, 1360–71.CrossRefGoogle Scholar

Chan, et al. (2006). The polarity protein Par-3 directly interacts with p75NTR to regulate myelination. Science 314, 832–6.CrossRefGoogle ScholarPubMed

Chan, J. R., Cosgaya, J. M., Wu, Y. J. and Shooter, E. M. (2001). Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Nat Acad Sci USA 98, 14661–8.CrossRefGoogle ScholarPubMed

Chan, J. R., Watkins, T. A., Cosgaya, J. M.et al. (2004). NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43, 183–91.CrossRefGoogle ScholarPubMed

Chance, P. F., Alderson, M. K., Leppig, K. A.et al. (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143–51.CrossRefGoogle ScholarPubMed

Chandross, K. J., Spray, D. C., Cohen, R. I.et al. (1996). TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol Cell Neurosci 7, 479–500.CrossRefGoogle ScholarPubMed

Chao, C. C. and Hu, S. (1994). Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 16, 172–9.CrossRefGoogle ScholarPubMed

Charcot, JM. and Marie, P. (1886). Sure une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteingnant plus tard les mains. Rev Med(Paris) 6, 97–138.Google Scholar

Chen, C., Bharucha, V., Chen, Y.et al. (2002). Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel β2-subunits. Proc Nat Acad Sci USA 99, 17072–7.CrossRefGoogle Scholar

Chen, C. L., Westenbroek, R. E., Xu, X. R.et al. (2004). Mice lacking sodium channel beta 1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 24, 4030–42.CrossRefGoogle Scholar

Chen, L. and Ko, C. P. (1994). Extension of synaptic extracellular matrix during nerve terminal sprouting in living frog neuromuscular junctions. J Neurosci 14, 796–808.CrossRefGoogle ScholarPubMed

Chen, L. E., Seaber, A. V., Wong, G. H. and Urbaniak, J. R. (1996). Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve. Neurochem Int 29, 197–203.Google ScholarPubMed

Chen, L. L., Folsom, D. B. and Ko, C. P. (1991). The remodeling of synaptic extracellular matrix and its dynamic relationship with nerve terminals at living frog neuromuscular junctions. J Neurosci 11, 2920–30.CrossRefGoogle ScholarPubMed

Chen, L. M., Bailey, D. and Fernandez-Valle, C. (2000). Association of beta 1 integrin with focal adhesion kinase and paxillin in differentiating Schwann cells. J Neurosci 20, 3776–84.CrossRefGoogle Scholar

Chen, S., Rio, C., Ji, R. R., Dikkes, P., Coggeshall, R. E., Woolf, C. J. and Corfas, G. (2003). Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6, 1186–93.CrossRefGoogle ScholarPubMed

Chen, Z. L. and Strickland, S. (2003). Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 163, 889–99.CrossRefGoogle ScholarPubMed

Cheng, H. L., Russell, J. W. and Feldman, E. L. (1999). IGF-I promotes peripheral nervous system myelination. Ann NY Acad Sci 883, 124–30.CrossRefGoogle ScholarPubMed

Cheng, H. L., Steinway, M., Delaney, C. L., Franke, T. F. and Feldman, E. L. (2000). IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol Cell Endocrinol 170, 211–15.CrossRefGoogle ScholarPubMed

Chernousov, M. A., Rothblum, K., Tyler, W. A., Stahl, R. C. and Carey, D. J. (2000). Schwann cells synthesize type V collagen that contains a novel alpha 4 chain. Molecular cloning, biochemical characterization, and high affinity heparin binding of alpha 4(V) collagen. J Biol Chem 275, 28208–15.Google ScholarPubMed

Chernousov, M. A. and Carey, D. J. (2003). AlphaVbeta8 integrin is a Schwann cell receptor for fibrin. Exp Cell Res 291, 514–24.CrossRefGoogle ScholarPubMed

Chernousov, M. A., Stahl, R. C. and Carey, D. J. (2001). Schwann cell type V collagen inhibits axonal outgrowth and promotes Schwann cell migration via distinct adhesive activities of the collagen and noncollagen domains. J Neurosci 21, 6125–35.CrossRefGoogle ScholarPubMed

Chiba, A., Kusunoki, S., Shimizu, T. and Kanazawa, I. (1992). Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller–Fisher syndrome. Ann Neurol 31, 677–9.CrossRefGoogle ScholarPubMed

Chiba, A., Matsumura, K., Yamada, H.et al. (1997). Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 272, 2156–62.CrossRefGoogle ScholarPubMed

Chiu, S. Y., Schrager, P. and Ritchie, J. M. (1984). Neuronal-type Na+ and K+ channels in rabbit cultured Schwann cells. Nature 311, 156–7.CrossRefGoogle Scholar

Chow, I. and Poo, M. M. (1985). Release of acetylcholine from embryonic neurons upon contact with muscle cell. J Neurosci 5, 1076–82.CrossRefGoogle ScholarPubMed

Christopherson, K. S., Ullian, E. M., Stokes, C. C.et al. (2005). Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421–33.CrossRefGoogle ScholarPubMed

Chun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A. and Vartanian, T. (2003). Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol 163, 397–408.CrossRefGoogle ScholarPubMed

Cifuentes-Diaz, C., Velasco, E., Meunier, F. A.et al. (1998). The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. Cell Mol Biol (Noisy-le-Grand) 44, 357–79.Google ScholarPubMed

Ciment, G. (1990). The melanocyte Schwann cell progenitor: a bipotent intermediate in the neural crest lineage. Comments Dev Neurobiol 1, 207–23.Google Scholar

Clegg, D. O., Wingerd, K. L., Hikita, S. T. and Tolhurst, E. C. (2003). Integrins in the development, function and dysfunction of the nervous system. Front Biosci 8, 723–50.CrossRefGoogle Scholar

Colby, J., Nicholson, R., Dickson, K. M.et al. (2000). PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis 7, 561–73.CrossRefGoogle ScholarPubMed

Colognato, H., Winkelmann, D. A. and Yurchenco, P. D. (1999). Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 145, 619–31.CrossRefGoogle ScholarPubMed

Colomar, A. and Robitaille, R. (2004). Glial modulation of synaptic transmission at the neuromuscular junction. Glia 47, 284–9.CrossRefGoogle ScholarPubMed

Constable, A. L., Armati, P. J., Toyka, K. V. and Hartung, H. P. (1994). Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 635, 75–80.CrossRefGoogle ScholarPubMed

Constable, A. L., Armati, P. J. and Hartung, H. P. (1999). DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells. J Neurol Sci 162, 120–6.CrossRefGoogle ScholarPubMed

Constantin, G., Piccio, L., Bussini, S.et al. (1999). Induction of adhesion molecules on human Schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci 170, 124–30.CrossRefGoogle ScholarPubMed

Constantinescu, C. S., Hilliard, B., Lavi, E., Ventura, E., Venkatesh, V. and Rostami, A. (1996). Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline. J Neurol Sci 143, 14–18.CrossRefGoogle ScholarPubMed

Cook, D. N., Pisetsky, D. S. and Schwartz, D. A. (2004). Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5, 975–9.CrossRefGoogle ScholarPubMed

Corbin, J. G., Kelly, D., Rath, E. M., Baerwald, K. D., Suzuki, K. and Popko, B. (1996). Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7, 354–70.CrossRefGoogle ScholarPubMed

Corfas, G., Velardez, M. O., Ko, C. P., Ratner, N. and Peles, E. (2004). Mechanisms and roles of axon–Schwann cell interactions. J Neurosci 24, 9250–60.CrossRefGoogle ScholarPubMed

Court, F. A., Sherman, D. L., Pratt, T.et al. (2004). Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431, 191–5.CrossRefGoogle ScholarPubMed

Couteaux, R. (1938). Sur l'origine de la sole des plaques motrices. C R Soc Biol 127, 218–21.Google Scholar

Couteaux, R. (1973). Motor end-plate structure. Bourne, G. H. (Ed.) The Structure and Function of Muscle, 2nd Edn. Academic Press, New York, pp. 483–530.Google Scholar

Coyle, A. J. and Gutierrez-Ramos, J. C. (2001). The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2, 203–9.CrossRefGoogle ScholarPubMed

Crawford, K. and Armati, P. J. (1982). The development of human fetal dorsal root ganglia in vitro: the first 20 days. Neuropathol Appl Neurobiol 8, 477–88.CrossRefGoogle ScholarPubMed

Cuesta, A., Pedrola, L., Sevilla, T.et al. (2001). The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot–Marie–Tooth type 4A disease. Nat Genet 30, 22–5.CrossRefGoogle ScholarPubMed

Culican, S. M., Nelson, C. C. and Lichtman, J. W. (1998). Axon withdrawal during synapse elimination at the neuromuscular junction is accompanied by disassembly of the postsynaptic specialization and withdrawal of Schwann cell processes. J Neurosci 18, 4953–65.CrossRefGoogle ScholarPubMed

Cummings, J. F., Lahunta, A. and Mitchell, W. J. Jr. (1983). Ganglioradiculitis in the dog. A clinical, light- and electron-microscopic study. Acta Neuropathol (Berl) 60, 29–39.CrossRefGoogle ScholarPubMed

Custer, A. W., Kazarinov-Noyes, K., Sakurai, T.et al. (2003). The role of the ankyrin-binding protein NrCAM in node of Ranvier formation. J Neurosci 23, 10032–9.CrossRefGoogle ScholarPubMed

D'Antonio, M., Drogitti, A., Feltri, M. L.et al. (2006). TGF beta type II recepter signalling controls Schwann cell death and proliferation in developing nerves. J Neurosci 26, 8417–27.CrossRefGoogle Scholar

D'Urso, D., Brophy, P. J., Staugaitis, S. M.et al. (1990). Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4, 449–60.CrossRefGoogle ScholarPubMed

Dahl, G., Werner, R., Levine, E. and Rabadan-Diehl, C. (1992). Mutational analysis of gap junction formation. Biophys J 62, 172–80.CrossRefGoogle ScholarPubMed

Dahle, C., Ekerfelt, C., Vrethem, M., Samuelsson, M. and Ernerudh, J. (1997). T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain–Barré syndrome. J Neurol Sci 153, 54–60.CrossRefGoogle Scholar

Dalakas, M. C. and Engel, W. K. (1981). Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 9 Suppl, 134–45.CrossRefGoogle ScholarPubMed

Daniloff, J. K., Crossin, K. L., Pincon-Raymond, M., Murawsky, M., Rieger, F. and Edelman, G. M. (1989). Expression of cytotactin in the normal and regenerating neuromuscular system. J Cell Biol 108, 625–35.CrossRefGoogle ScholarPubMed

Darbas, A., Jaegle, M., Walbeehm, E.et al. (2004). Cell autonomy of the mouse claw paw mutation. Develop Biol 272, 470–82.CrossRefGoogle ScholarPubMed

Day, N. C., Wood, S. J., Ince, P. G.et al. (1997). Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction. J Neurosci 17, 6226–35.CrossRefGoogle ScholarPubMed

Waegh, S. and Brady, S. T. (1990). Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 10, 1855–65.CrossRefGoogle Scholar

Waegh, S. M., Lee, V. M. and Brady, S. T. (1992). Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451–63.CrossRefGoogle ScholarPubMed

Dedek, K., Kunath, B., Kananura, C., Reuner, U., Jentsch, T. and Steinlein, O. K. (2001). Myokymia and neonatal epilepsy caused by a mutation in the voltage sensory of the KCNQ2 K − channel. Proc Nat Acad Sci USA 98, 12272–7.CrossRefGoogle Scholar

Delpech, A., Girard, N. and Delpech, B. (1982). Localization of hyaluronectin in the nervous system. Brain Res 245, 251–7.CrossRefGoogle Scholar

Dennis, M. J. and Miledi, R. (1974). Electrically induced release of acetylcholine from denervated Schwann cells. J Physiol 237, 431–52.CrossRefGoogle ScholarPubMed

Deodato, F., Sabatelli, M., Ricci, E.et al. (2002). Hypermyelinating neuropathy, mental retardation and epilepsy in a case of merosin deficiency. Neuromuscul Dis 12, 329–98.CrossRefGoogle Scholar

Desaki, J. and Uehara, Y. (1981). The overall morphology of neuromuscular junctions as revealed by scanning electron microscopy. J Neurocytol 10, 101–10.CrossRefGoogle ScholarPubMed

Descarries, L. M., Cai, S., Robitaille, R., Josephson, E. M. and Morest, D. K. (1998). Localization and characterization of nitric oxide synthase at the frog neuromuscular junction. J Neurocytol 27, 829–40.CrossRefGoogle ScholarPubMed

Deschenes, S. M., Walcott, J. L., Wexler, T. L., Scherer, S. S. and Fischbeck, K. H. (1997). Altered trafficking of mutant connexin32. J Neurosci 17, 9077–84.CrossRefGoogle ScholarPubMed

Devaux, J. J. and Scherer, S. S. (2005). Altered ion channels in an animal model of Charcot–Marie–Tooth disease type IA. J Neurosci 25, 1470–80.CrossRefGoogle Scholar

Devaux, J., Alcaraz, G., Grinspan, J.et al. (2003). Kv3.1 is a novel component of CNS nodes. J Neurosci 23, 4509–18.CrossRefGoogle Scholar

Devaux, J. J., Kleopas, A. K., Cooper, E. C. and Scherer, S. S. (2004). KCNQ2 is a nodal K+ channel. J Neurosci 24, 1236–44.CrossRefGoogle ScholarPubMed

Di Muzio, A., Angelis, M. V., Di Fulvio, P.et al. (2003). Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Muscle Nerve 27, 500–6.CrossRefGoogle ScholarPubMed

Dickens, P., Hill, P. and Bennett, M. R. (2003). Schwann cell dynamics with respect to newly formed motor-nerve terminal branches on mature (Bufo marinus) muscle fibers. J Neurocytol 32, 381–92.CrossRefGoogle ScholarPubMed

Doetsch, F. (2003). The glial identity of neural stem cells. Nature Neurosci 6, 1127–34.CrossRefGoogle ScholarPubMed

Donaghy, M., Gray, J. A., Squier, W.et al. (1989). Recurrent Guillain–Barré syndrome after multiple exposures to cytomegalovirus. Am J Med 87, 339–41.CrossRefGoogle ScholarPubMed

Dong, Z., Brennan, A., Liu, N.et al. (1995). Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15, 585–96.CrossRefGoogle ScholarPubMed

Dong, Z., Sinanan, A., Parkinson, D., Parmantier, E., Mirsky, R. and Jessen, K. R. (1999). Schwann cell development in embryonic mouse nerves. J Neurosci Res 56, 334–48.3.0.CO;2-#>CrossRefGoogle ScholarPubMed

Dore-Duffy, P., Balabanov, R., Washington, R. and Swanborg, R. H. (1994). Transforming growth factor beta 1 inhibits cytokine-induced CNS endothelial cell activation. Mol Chem Neuropathol 22, 161–75.CrossRefGoogle ScholarPubMed

Dowsing, B. J., Morrison, W. A., Nicola, N. A., Starkey, G. P., Bucci, T. and Kilpatrick, T. J. (1999). Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 73, 96–104.CrossRefGoogle ScholarPubMed

Duggins, A. J., McLeod, J. G., Pollard, J. D.et al. (1999). Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122 (Part 7), 1383–90.CrossRefGoogle ScholarPubMed

Dulac, C. and Douarin, N. M. (1991). Phenotypic plasticity of Schwann cells and enteric glial cells in response to the microenvironment. Proc Nat Acad Sci USA 88, 6358–62.CrossRefGoogle ScholarPubMed

Dunaevsky, A. and Connor, E. A. (1995). Long-term maintenance of presynaptic function in the absence of target muscle fibers. J Neurosci 15, 6137–44.CrossRefGoogle ScholarPubMed

Dunaevsky, A. and Connor, E. A. (1998). Stability of frog motor nerve terminals in the absence of target muscle fibers. Dev Biol 194, 61–71.CrossRefGoogle ScholarPubMed

Dunaevsky, A. and Connor, E. A. (2000). F-actin is concentrated in nonrelease domains at frog neuromuscular junctions. J Neurosci 20, 6007–12.CrossRefGoogle ScholarPubMed

Dupin, E., Baroffio, A., Dulac, C., Cameron-Curry, P. and Douarin, N. M. (1990). Schwann-cell differentiation in clonal cultures of the neural crest, as evidenced by the anti-Schwann cell myelin protein monoclonal antibody. Proc Nat Acad Sci USA 87, 1119–23.CrossRefGoogle ScholarPubMed

Dupin, E., Glavieux, C., Vaigot, P. and Douarin, N. M. (2000). Endothelin 3 induces the reversion of melanocytes to glia through a neural crest-derived glial-melanocytic progenitor. Proc Nat Acad Sci USA 97, 7882–7.CrossRefGoogle ScholarPubMed

Dupin, E., Real, C., Glavieux-Pardanaud, C., Vaigot, P. and Douarin, N. M. (2003). Reversal of developmental restrictions in neural crest lineages: transition from Schwann cells to glial-melanocytic precursors in vitro. Proc Nat Acad Sci USA 100, 5229–33.CrossRefGoogle ScholarPubMed

Dyck, P. J. (1975). Inherited neuronal degeneration and atrophy affecting peripheral motor, sensory and autonomic neurons. Dyck, P. J. (Ed.) Peripheral Neuropathy, 1st Edn. W.B. Saunders, Philadelphia, p. 825.Google ScholarPubMed

Dyck, P. J. and Lambert, E. H. (1968a). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18, 603–18.CrossRefGoogle Scholar

Dyck, P. J. and Lambert, E. H. (1968b). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18, 619–25.CrossRefGoogle Scholar

Dyck, P. J., Lais, A. C., Ohta, M., Bastron, J. A., Okazaki, H. and Groover, R. V. (1975). Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50, 621–37.Google ScholarPubMed

Dytrych, L., Sherman, D. L., Gillespie, C. S. and Brophy, P. J. (1998). Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem 273, 5794–800.CrossRefGoogle ScholarPubMed

Eccleston, P. A. (1992). Regulation of Schwann cell proliferation: mechanisms involved in peripheral nerve development. Expe Cell Res 199, 1–9.CrossRefGoogle ScholarPubMed

Eccleston, P. A., Jessen, K. R. and Mirsky, R. (1989). Transforming growth factor-beta and gamma-interferon have dual effects on growth of peripheral glia. J Neurosci Res 24, 524–30.CrossRefGoogle ScholarPubMed

EFN and PNS Task Force (2005). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10, 220–8.CrossRef

Eichberg, J. and Iyer, S. (1996). Phosphorylation of myelin protein: recent advances. Neurochem Res 21, 527–35.CrossRefGoogle ScholarPubMed

Einheber, S., Milner, T. A., Giancotti, F. and Salzer, J. L. (1993). Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol 123, 1223–6.CrossRefGoogle ScholarPubMed

Einheber, S., Hannocks, M. J., Metz, C. N., Rifkin, D. B. and Salzer, J. L. (1995). Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J Cell Biol 129, 443–58.CrossRefGoogle ScholarPubMed

Eldridge, C. F., Bunge, M. B., Bunge, R. P. and Wood, P. M. (1987). Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 105, 1023–34.CrossRefGoogle ScholarPubMed

Eldridge, C. F., Bunge, M. B. and Bunge, R. P. (1989). Differentiation of axon-related Schwann cell in vitro: II. Control of myelin formation by basal lamina. J Neurosci 9, 625–38.CrossRefGoogle ScholarPubMed

Elson, K., Ribeiro, R. M., Perelson, A. S., Simmons, A. and Speck, P. (2004). The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine. Exp Neurol 186, 99–103.CrossRefGoogle ScholarPubMed

Empl, M., Renaud, S., Erne, B.et al. (2001). TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56, 1371–7.CrossRefGoogle ScholarPubMed

Engel, A. G. (1994). The neuromuscular junction. Engel, A. G., Franzini-Armstrong, C. (Eds.) Myology. McGraw-Hill Professional, New York.Google Scholar

English, A. W. (2003). Cytokines, growth factors and sprouting at the neuromuscular junction. J Neurocytol 32, 943–60.CrossRefGoogle ScholarPubMed

Erdman, R., Stahl, R. C., Rothblum, K., Chernousov, M. A. and Carey, D. J. (2002). Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3. J Biol Chem 277, 7619–25.CrossRefGoogle ScholarPubMed

Ersdal, C., Ulvund, M. J., Espenes, A., Benestad, S. L., Sarradin, P. and Landsverk, T. (2005). Mapping PrPSc propagation in experimental and natural scrapie in sheep with different PrP genotypes. Vet Pathol 42, 258–74.CrossRefGoogle ScholarPubMed

Ervasti, J. M. and Campbell, K. P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122, 809–23.CrossRefGoogle ScholarPubMed

Exley, A. R., Smith, N. and Winer, J. B. (1994). Tumour necrosis factor-alpha and other cytokines in Guillain–Barré syndrome. J Neurol Neurosurg Psych 57, 1118–20.CrossRefGoogle ScholarPubMed

Eylar, E. H., Uyemura, K., Brostoff, S. W., Kitamura, K., Ishaque, A. and Greenfield, S. (1979). Proposed nomenclature for PNS myelin proteins. Neurochem Res 4, 289–93.CrossRefGoogle ScholarPubMed

Fabry, Z., Topham, D. J., Fee, D.et al. (1995). TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 155, 325–32.Google ScholarPubMed

Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284, 14–30.CrossRefGoogle ScholarPubMed

Fannon, A. M., Sherman, D. L., Ilyina-Gragerova, G., Brophy, P. J., Friedrich, V. L. Jr. and Colman, D. R. (1995). Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 129, 189–202.CrossRefGoogle ScholarPubMed

Feasby, T. E., Hahn, A. F. and Gilbert, J. J. (1982). Passive transfer studies in Guillain–Barré polyneuropathy. Neurology 32, 1159–67.CrossRefGoogle ScholarPubMed

Feasby, T. E., Gilbert, J. J., Brown, W. F.et al. (1986). An acute axonal form of Guillain–Barré polyneuropathy. Brain 109 (Part 6), 1115–26.CrossRefGoogle ScholarPubMed

Feasby, T. E., Hahn, A. F., Brown, W. F., Bolton, C. F. and Gilbert, J. J. (1988). Two types of axonal degeneration in acute Guillain–Barré syndrome. J Neurol 235, S15.Google Scholar

Feder, N. (1971). Microperoxidase – an ultrastructural tracer of low molecular weight. J Cell Biol 51, 339–43.CrossRefGoogle ScholarPubMed

Feltri, M. L. and Wrabetz, L. (2005). Laminins and their receptors in Schwann cells and hereditary neuropathies. J Peripher Nerv Syst 10, 128–43.CrossRefGoogle ScholarPubMed

Feltri, M. L., Scherer, S. S., Nemni, R.et al. (1994). β4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 120, 1287–1301.Google ScholarPubMed

Feltri, M. L., Arona, M., Scherer, S. S. and Wrabetz, L. (1997). Cloning and sequence of the cDNA encoding the beta 4 integrin subunit in rat peripheral nerve. Gene 186, 299–304.CrossRefGoogle ScholarPubMed

Feltri, M. L., Graus, P. D., Previtali, S. C.et al. (2002). Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 156, 199–209.CrossRefGoogle Scholar

Feng, Z. and Ko, C. P. (2004). Transforming growth factor (TGF)-beta 1 mediates Schwann cell-induced synaptogenesis at the neuromuscular junction in vitro. Program No 385 18, Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience.

Feng, G., Mellor, R. H., Bernstein, M.et al. (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51.CrossRefGoogle ScholarPubMed

Feng, Z., Koirala, S. and Ko, C. P. (2005). Synapse–glia interactions at the vertebrate neuromuscular junction. Neuroscientist 11, 503–13.CrossRefGoogle ScholarPubMed

Fenzi, F., Benedetti, M. D., Moretto, G. and Rizzuto, N. (2001). Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immunocytochemical and morphometric study. Arch Ital Biol 139, 357–65.Google ScholarPubMed

Fernandez-Valle, C., Gwynn, L., Wood, P. M., Carbonetto, S. and Bunge, M. B. (1994). Anti-beta 1 integrin antibody inhibits Schwann cell myelination. J Neurobiol 25, 1207–26.CrossRefGoogle ScholarPubMed

Fernandez-Valle, C., Tang, Y., Ricard, J.et al. (2002). Paxillin binds Schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31, 354–62.CrossRefGoogle ScholarPubMed

Fields, R. D. and Stevens, B. (2000). ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23, 625–33.CrossRefGoogle ScholarPubMed

Fields, R. D. and Stevens-Graham, B. (2002). New insights into neuron–glia communication. Science 298, 556–62.CrossRefGoogle ScholarPubMed

Filbin, M. T., Walsh, F. S., Trapp, B. D., Pizzey, J. A. and Tennekoon, G. I. (1990). Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344, 871–2.CrossRefGoogle ScholarPubMed

Filbin, M. T., Zhang, K., Li, W. and Gao, Y. (1999). Characterization of the effect on adhesion of different mutations in myelin P0 protein. Ann NY Acad Sci 883, 160–7.CrossRefGoogle ScholarPubMed

Fisher, M. (1956). Syndrome of ophthalmoplegia, ataxia and areflexia. New Engl J Med 255, 57–65.CrossRefGoogle ScholarPubMed

Foote, A. K. and Blakemore, W. F. (2005). Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128, 528–39.CrossRefGoogle ScholarPubMed

Forsberg, E., Ek, B., Engstrom, A. and Johansson, S. (1994). Purification and characterization of integrin alpha 9 beta 1. Exp Cell Res 213, 183–90.CrossRefGoogle ScholarPubMed

Fortun, J., Dunn, W. A. Jr., Joy, S., Li, J. and Notterpek, L. (2003). Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23, 10672–80.CrossRefGoogle ScholarPubMed

Fortun, J., Li, J., Go, J., Fenstermaker, A., Fletcher, B. S. and Notterpek, L. (2005). Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J Neurochem 92, 1531–41.CrossRefGoogle Scholar

Fragoso, G., Robertson, J., Athlan, E., Tam, E., Almazan, G. and Mushynski, W. E. (2003). Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination. Exp Neurol 183, 34–46.CrossRefGoogle ScholarPubMed

Frampton, G., Winer, J. B., Cameron, J. S. and Hughes, R. A. (1988). Severe Guillain–Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 19, 133–9.CrossRefGoogle Scholar

Franklin, R. J. (2002). Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull 57, 827–32.CrossRefGoogle ScholarPubMed

Franzke, C. W., Tasanen, K., Schumann, H. and Bruckner-Tuderman, L. (2003). Collagenous transmembrane proteins: collagen XVII as a prototype. Matrix Biol 22, 299–309.CrossRefGoogle ScholarPubMed

Frei, R., Dowling, J., Carenini, S., Fuchs, E. and Martini, R. (1999). Myelin formation by Schwann cells in the absence of beta4 integrin. Glia 27, 269–74.3.0.CO;2-2>CrossRefGoogle ScholarPubMed

French Cooperative Group on Plasma Exchange in Guillain–Barré syndrome (1987). Efficiency of plasma exchange in Guillain–Barré syndrome: role of replacement fluids. Ann Neurol 22, 753–61.CrossRef

Frostick, S. P., Yin, Q. and Kemp, G. J. (1998). Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 18, 397–405.3.0.CO;2-F>CrossRefGoogle ScholarPubMed

Fu, S. Y. and Gordon, T. (1997). The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14, 67–116.CrossRefGoogle ScholarPubMed

Fujii, K., Tsuji, M. and Murota, K. (1986). Isolation of peripheral nerve collagen. Neurochem Res 11, 1439–46.CrossRefGoogle ScholarPubMed

Fujioka, T., Purev, E. and Rostami, A. (1999a). Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. J Neuroimmunol 97, 51–9.CrossRefGoogle Scholar

Fujioka, T., Kolson, D. L. and Rostami, A. M. (1999b). Chemokines and peripheral nerve demyelination. J Neurovirol 5, 27–31.CrossRefGoogle Scholar

Fuller, G. N., Spies, J. M., Pollard, J. D. and McLeod, J. G. (1994). Demyelinating neuropathies triggered by melanoma immunotherapy. Neurology 44, 2404–5.CrossRefGoogle ScholarPubMed

Gaboreanu, A., Hrstka, R., Xu, W.et al. (2004). A New Protein that Interacts with the Cytoplasmic Domain of P0. Am Society for Cell Biology Annual Meeting, Washington DC.Google Scholar

Gabriel, C. M., Hughes, R. A., Moore, S. E., Smith, K. J. and Walsh, F. S. (1998). Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 121 (Part 10), 1895–902.CrossRefGoogle ScholarPubMed

Gabriel, C. M., Gregson, N. A. and Hughes, R. A. (2000). Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 104, 139–46.CrossRefGoogle ScholarPubMed

Gadient, R. A. and Otten, U. (1996). Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res 724, 41–6.CrossRefGoogle ScholarPubMed

Gambardella, A., Bono, F., Muglia, M., Valentino, P. and Quattrone, A. (1999). Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Ann NY Acad Sci 883, 47–55.CrossRefGoogle Scholar

Garbay, B., Heape, A. M., Sargueil, F. and Cassagne, C. (2000). Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61, 267–304.CrossRefGoogle ScholarPubMed

Garbern, J. Y., Cambi, F., Tang, X. M.et al. (1997). Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19, 205–18.CrossRefGoogle ScholarPubMed

Garratt, A. N., Britsch, S. and Birchmeier, C. (2000a). Neuregulin, a factor with many functions in the life of a Schwann cell. Bioessays 22, 987–96.3.0.CO;2-5>CrossRefGoogle Scholar

Garratt, A. N., Voiculescu, O., Topilko, P., Charnay, P. and Birchmeier, C. (2000b). A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J Cell Biol 148, 1035–46.CrossRefGoogle Scholar

Gatto, C. L., Walker, B. J. and Lambert, S. (2003). Local ERM activation and dynamic growth cones at Schwann cell tips implicated in efficient formation of nodes of Ranvier. J Cell Biol 162, 489–98.CrossRefGoogle ScholarPubMed

George, A., Schmidt, C., Weishaupt, A., Toyka, K. V. and Sommer, C. (1999). Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 160, 124–32.CrossRefGoogle ScholarPubMed

George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. and Hynes, R. O. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079–91.Google ScholarPubMed

Georges-Labouesse, E. N., George, E. L., Rayburn, H. and Hynes, R. O. (1996). Mesodermal development in mouse embryos mutant for fibronectin. Dev Dyn 207, 145–56.3.0.CO;2-H>CrossRefGoogle ScholarPubMed

Georgiou, J. and Charlton, M. P. (1999). Non-myelin-forming perisynaptic Schwann cells express protein zero and myelin-associated glycoprotein. Glia 27, 101–9.3.0.CO;2-H>CrossRefGoogle ScholarPubMed

Georgiou, J., Robitaille, R., Trimble, W. S. and Charlton, M. P. (1994). Synaptic regulation of glial protein expression in vivo. Neuron 12, 443–55.CrossRefGoogle ScholarPubMed

Ghabriel, M. N. and Allt, G. (1981). Incisures of Schmidt–Lanterman. Prog Neurobiol 17, 25–58.CrossRefGoogle ScholarPubMed

Ghazvini, M., Mandemakers, W., Jaegle, M.et al. (2002). A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J 21, 4612–20.CrossRefGoogle ScholarPubMed

Ghislain, J., Desmarquet-Trin-Dinh, C., Jaegle, M., Meijer, D., Charnay, P. and Frain, M. (2002). Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129, 155–66.Google ScholarPubMed

Giese, K. P., Martini, R., Lemke, G., Soriano, P. and Schachner, M. (1992). Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565–76.CrossRefGoogle ScholarPubMed

Gillespie, C. S., Sherman, D. L., Blair, G. E. and Brophy, P. J. (1994). Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12, 497–508.CrossRefGoogle ScholarPubMed

Girard, C., Bemelmans, A. P., Dufour, N.et al. (2005). Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 25, 7924–33.CrossRefGoogle ScholarPubMed

Girault, J. A., Oguievetskaia, K., Carnaud, M., Denisenko-Nehrbass, N. and Goutebroze, L. (2003). Transmembrane scaffolding proteins in the formation and stability of nodes of Ranvier. Biol Cell 95, 447–52.CrossRefGoogle ScholarPubMed

Gleichmann, M., Gillen, C., Czardybon, M.et al. (2000). Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci 12, 1857–66.CrossRefGoogle Scholar

Godschalk, P. C., Heikema, A. P., Gilbert, M.et al. (2004). The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain–Barré syndrome. J Clin Invest 114, 1659–65.CrossRefGoogle ScholarPubMed

Gold, R., Toyka, K. V. and Hartung, H. P. (1995). Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165, 65–70.CrossRefGoogle ScholarPubMed

Gold, R., Archelos, J. J. and Hartung, H. P. (1999). Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol 9, 343–60.CrossRefGoogle ScholarPubMed

Gold, R., Hartung, H. P. and Toyka, K. V. (2000). Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 6, 88–91.CrossRefGoogle ScholarPubMed

Gollan, L., Salomon, D., Salzer, J. L. and Peles, E. (2003). Caspr regulates the processing of contactin and inhibits its binding to neurofascin. J Cell Biol 163, 1213–18.CrossRefGoogle ScholarPubMed

Gonzalez-Martinez, T., Perez-Pinera, P., Diaz-Esnal, B. and Vega, J. A. (2003). S-100 proteins in the human peripheral nervous system. Microsc Res Tech 60, 633–8.CrossRefGoogle ScholarPubMed

Goodyear, C. S., O'Hanlon, G. M., Plomp, J. J.et al. (1999). Monoclonal antibodies raised against Guillain–Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle–nerve preparations. J Clin Invest 104, 697–708.CrossRefGoogle ScholarPubMed

Gorson, K. C., Allam, G. and Ropper, A. H. (1997). Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48, 321–8.CrossRefGoogle ScholarPubMed

Gorson, K. C. and Chaudhry, V. (1999). Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol 1, 251–62.CrossRefGoogle ScholarPubMed

Gotz, M. (2003). Glial cells generate neurons – master control within CNS regions: developmental perspectives on neural stem cells. Neuroscientist 9, 379–97.CrossRefGoogle ScholarPubMed

Gotz, M. and Barde, Y. A. (2005). Radial glial cells: defined and major intermediates between embryonic stem cells and CNS neurons. Neuron 46, 369–72.CrossRefGoogle ScholarPubMed

Goutebroze, L., Carnaud, M., Denisenko, N., Boutterin, M. C. and Girault, J. A. (2003). Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes. BMC Neurosci 4, 29.CrossRefGoogle ScholarPubMed

Greenfield, S., Brostoff, S., Eylar, E. H. and Morell, P. (1973). Protein composition of myelin of the peripheral nervous system. J Neurochem 20, 1207–16.CrossRefGoogle ScholarPubMed